Prostate Cancer: Epidemiology and Pathogenesis: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 62: | Line 62: | ||
*##*** '''Stronger association between BRCA2, compared to BRCA1, with both incidence and aggressive cancer''' | *##*** '''Stronger association between BRCA2, compared to BRCA1, with both incidence and aggressive cancer''' | ||
*##*** '''Systematic PSA screening is indicated''' | *##*** '''Systematic PSA screening is indicated''' | ||
*##** '''<span style="color:#ff0000">Hereditary breast and ovarian cancer syndrome</span>''' | *##** '''<span style="color:#ff0000">Hereditary breast and ovarian cancer syndrome (HBOC)</span>''' | ||
*##*** '''Most commonly associated with mutations in either the BRCA1 or BRCA2 gene''' | *##*** '''Most commonly associated with mutations in either the BRCA1 or BRCA2 gene''' | ||
*##*** '''<span style="color:#ff0000">Associated cancers (5):[https://www.ncbi.nlm.nih.gov/books/NBK1247/]</span>''' | *##*** '''<span style="color:#ff0000">Associated cancers (5):[https://www.ncbi.nlm.nih.gov/books/NBK1247/]</span>''' | ||